SCHEMBL3514697

SCHEMBL3514697

O=c1cc(-c2cccc(CN3CCN(Cc4ccccc4)CC3)c2)c2cccnc2n1OCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.44
DRD4 P21917 6/20 0.44
DRD3 P35462 6/20 0.44
LMNA P02545 3/20 0.41
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 2/20 0.41
TSHR P16473 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
ALOX12 P18054 1/20 0.41
CA12 O43570 3/20 0.41
CA9 Q16790 3/20 0.41
USP2 O75604 2/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3517696 0.86 ALDH1A1 (0.40) LMNAALDH1A1SMN1; SMN2HTTTSHR
SCHEMBL3519074 0.85 PIK3CD (0.44) LMNAALDH1A1SMN1; SMN2HTTTSHR
SCHEMBL3515937 0.84 DRD2 (0.47) DRD2DRD4DRD3ALDH1A1TSHR
SCHEMBL3515749 0.82 MAOA (0.42) ALDH1A1TSHRALOX15MAPTNPC1
SCHEMBL3516281 0.78 GRK2 (0.42) ALDH1A1TSHR
SCHEMBL3519661 0.74 HDAC1 (0.44) DRD2DRD4DRD3ALDH1A1USP2
SCHEMBL3515379 0.74 KDM4E (0.45) LMNAALDH1A1SMN1; SMN2HTTTSHR
SCHEMBL3514631 0.74 ALDH1A1 (0.41) LMNAALDH1A1SMN1; SMN2HTTTSHR
SCHEMBL3519489 0.74 KDR (0.46) DRD2DRD4DRD3FAAHMGLL
SCHEMBL3517744 0.72 CYP19A1 (0.35) LMNAALDH1A1SMN1; SMN2TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL DRD2 1821/4885DRD4 994/4885DRD3 1874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.